Enemem, Something happening with the high impacts (ala Servier) in the next 2-3 years could conceivably resurrect the stock. Then there's ADHD, which Varney should be able to partner sometime in 2011, though to get there I'm figuring on a $2-3 mil interim financing in the Mar-May period.
So the soap opera continues. It's an entertaining stock if you don't actually own it :o)